GL1X · GenesisL1 explorer

MolNFT v1 · #141945 · protein

EG5 motor domain in complex with stlc-type inhibitor PVEI0021 (C2 type)

5ZO9 · Kinesin-like protein KIF11: “EG5 motor domain in complex with stlc-type inhibitor PVEI0021 (C2 type)”. X-ray diffraction, 5 ligands (ADP, 4C5, MG), 6 pockets (best druggability 0.63). MolNFT v1 #141945 on GenesisL1: 3D structure…

PDB
5ZO9
Type
protein
Length
662 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Kinesin-like protein KIF11
UniProt
P52732
Ligands
ADP, 4C5, MG, NA, SO4
Pockets
6 · best druggability 0.63

Structure

x-ray diffraction · 1 distinct chain · 34% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BKinesin-like protein KIF11protein33134% helix, 29% strandP52732

Ligands and binding sites

  • ADP · Adenosine-5'-diphosphate · ligand · 2 copies · chains A, B
  • 4C5 · (2R)-2-azanyl-3-[(4-methoxyphenyl)-diphenyl-methyl]sulfanyl-propanoic acid · ligand · 2 copies · chains A, B
  • MG · Magnesium ion · metal · 2 copies · chains A, B
  • NA · Sodium ion · metal · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12910.630.8034empty
21640.630.84214C5
33080.610.7935empty
41630.590.82214C5
5770.410.8020MG

Compared structures

  • 5ZO9 · Eg5 motor domain in complex with STLC-type inhibitor PVEI0021 (C2 type) · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.